Abbott needs to conduct more performance testing to ensure its FreeStyle Libre devices are accurate, FDA inspectors found.

The purchase will give Medtronic a larger presence in the cath lab, with a tool to help diagnose and treat coronary artery ...

The company is searching for a new leader after former CEO Stephen Farrell left when STAAR shareholders rejected a buyout ...

Amid the upheaval, Grail continued to run studies to assess the ability of its Galleri blood test to detect a range of ...

The letter, which the FDA has not yet published, does not affect Beta Bionics’ ability to market, manufacture or distribute ...

From M&A to surgical robotics and user fee negotiations, the medical device industry has a busy year ahead. Check out MedTech ...

Stryker expects the robot, called Mako RPS, to bring in new customers, including more ambulatory surgery centers.

The lawsuit questions the Trump administration’s authority to make sweeping environmental exemptions without evidence.

With nine new procedures cleared for the da Vinci 5 robot, Intuitive’s strategy includes working with a limited number of U.S ...

Acquisitions and spinoffs in 2025 surpassed the previous three years, according to a report from Bain & Company.

With Waters stockholders voting to issue shares, the companies are targeting a Feb. 9 close date for the deal.

Experts say two new guidances — issued without the usual public comment period — leave questions about how patients will ...